Alpha 2.0
Login Register
» Articles » PMID: 35679027

Inclusion and Reporting of Transgender and Nonbinary Persons in Clinical Trials and Tumor Registries-The Time Is Now

Overview
Journal JAMA Oncol
Publisher American Medical Association
Specialty Oncology
Date 2022 Jun 9
PMID 35679027
Authors
Chandler S Cortina
Affiliations
Soon will be listed here.
Citing Articles

Gender-Affirming Hormone Therapy for Breast Cancer in Transgender and Gender-Diverse Individuals: Unresolved and Unaddressed Issues.

Rajput S, Jatoi A, Davidge-Pitts C, Cathcart-Rake E Mayo Clin Proc. 2024; 100(1):26-29.

PMID: 39641711 PMC: 11700775. DOI: 10.1016/j.mayocp.2024.10.002.

Prevalence and predictors of cancer screening in transgender and gender nonbinary individuals.

Lui M, Bockting W, Cato K, Houghton L Int J Transgend Health. 2024; 25(4):957-970.

PMID: 39465092 PMC: 11500587. DOI: 10.1080/26895269.2023.2294493.

Breast care considerations for transgender and gender-diverse patients.

Carroll E, Rogers C, Summerside M, Cortina C Womens Health (Lond). 2024; 20:17455057241289706.

PMID: 39382481 PMC: 11465296. DOI: 10.1177/17455057241289706.

The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals: A Pilot Single-Arm Educational Intervention Trial.

Cortina C, Purdy A, Brazauskas R, Stachowiak S, Fodrocy J, Klement K Ann Surg Oncol. 2024; 31(11):7474-7482.

PMID: 38940898 PMC: 11452287. DOI: 10.1245/s10434-024-15701-2.

Systematic Review on Gender-Affirming Testosterone Therapy and the Risk of Breast Cancer: A Challenge for Physicians Treating Patients from Transgender and Gender-Diverse Populations.

Pamulapati S, Conroy M, Cortina C, Harding E, Kamaraju S Arch Sex Behav. 2023; 53(5):1969-1980.

PMID: 38148450 DOI: 10.1007/s10508-023-02773-6.